SEARCH RESULTS

2 RESULTS

Daniel Gibbs on Aducanumab Approved to Treat Alzheimer’s Disease

COMMENT I have mixed feelings about this approval. As someone living with early stage Alzheimer’s who participated in the Engage trial, I am pleased that patients will now have access to the first drug shown to reduce brain amyloid and modestly slow progression ...

Current Filters

  • TYPE: Comment x
  • Commentator: Gibbs, Daniel x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE